{"gao_id": "GAO-12-500", "published": "2012-03-30T12:00:00Z", "released": "2012-04-30T08:00:00Z", "summary": "", "title": "Prescription Drugs: FDA Has Met Most Performance Goals for Reviewing Applications", "topics": ["Drugs", "Performance goals", "Corporate stakeholders", "Health Care", "Prescription drugs", "Biologics", "Advisory committees", "Health care", "User fees", "Patient care", "Drug safety"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-12-500", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-12-500-highlights.pdf"}, {"title": "Full Report (52 pages)", "url": "https://www.gao.gov/assets/gao-12-500.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/600/590533.txt"}]}